In accordance with our study, Fang et al. found that decreased miR-148b could enhance tumor cell proliferation and inhibit apoptosis in human renal cancer cells by targeting MAP3K9, which is a upstream activator of MAPK/JNK pathway [45]. Here, MAPK8 is linked to neoplasm.